Results 191 to 200 of about 183,086 (327)

Use of fluoxetine in heroin addiction [PDF]

, 1992
Icro Maremmani, Paolo Castrogiovanni, L. Daini, O. Zolesi   +3 more
openalex   +1 more source

Efficacy of a personalised alcohol approach bias modification smartphone app in people accessing outpatient alcohol use disorder treatment: A randomised controlled trial

Addiction, Volume 121, Issue 1, Page 82-93, January 2026.
Abstract Background and aims Several randomised controlled trials (RCTs) have demonstrated that delivering approach bias modification (ApBM) during residential alcohol use disorder (AUD) treatment helps prevent post‐treatment relapse. However, few studies have examined ApBM's efficacy for AUD in outpatients.
Joshua B. B. Garfield, Bosco Rowland, Samuel K. Liu, Hugh Piercy, Yvonne Bonomo, Danielle Whelan, Victoria Manning   +6 more
wiley   +1 more source

Letter: Heroin "epidemic"? [PDF]

, 1975
Leroy C. Gould, W D Thompson, Rosalie M. Berberian   +2 more
openalex   +1 more source

Characteristics of drug‐related deaths among individuals identified as LGBTQ+ in the United Kingdom, 1997–2024

Addiction, Volume 121, Issue 1, Page 208-214, January 2026.
Abstract Background and Aims Individuals from sexual and gender minorities (LGBTQ+) are understudied and at increased and differential risk of experiencing drug‐related harms when compared with the general population. We aimed to determine the case characteristics, circumstances of death and type of implicated drugs among LGBTQ+ individuals dying due ...
Emmert Roberts, Miriam Hillyard, Caroline Copeland   +2 more
wiley   +1 more source

Fentanyl, Amphetamine-type Stimulants, Heroin, and xylazine in drug residues in two Northern border Mexican cities. [PDF]

Harm Reduct J
Bautista CF, Medina-Mora ME, Cruz SL, López-Brambila MA, Miranda-Soto V, Chávez D, Mata J, Chávez A, Segovia L, Angulo L, Slim S, Pacheco L.   +11 more
europepmc   +1 more source

Glutamatergic neurons in ventral pallidum modulate heroin addiction via epithalamic innervation in rats [PDF]

Ruo-song Chen, Jing Liu, Yujun Wang, Kuan Ning, Jing‐Gen Liu, Zhiqiang Liu   +5 more
openalex   +1 more source

An exploratory analysis of 5‐alpha reductase inhibitors and risk of opioid use disorder among male Medicare beneficiaries receiving prescription opioid medications

The American Journal on Addictions, Volume 35, Issue 1, Page 46-52, January 2026.
Abstract Background Opioid use disorder (OUD) imposes a significant socioeconomic burden, highlighting the need for new interventions. Objective This study investigated whether exposure to 5‐alpha reductase inhibitors (5αRIs) is associated with a lower risk of developing OUD.
Abdelrahman G. Tawfik, Tyler Lister, Ainhoa Gomez‐Lumbreras, Randall T. Peterson, Marco Bortolato, Daniel C. Malone   +5 more
wiley   +1 more source

Persisting high rates of mental health disorders in patients in opioid agonist treatment—Results from a 6‐year longitudinal study

The American Journal on Addictions, Volume 35, Issue 1, Page 90-93, January 2026.
Abstract Background and Objectives There are hardly any data from longitudinal studies on the prevalence of mental health disorders in patients in opioid agonist therapy (OAT). Methods Here we report prevalence rates of mental health disorders in a 6‐year naturalistic noninterventional follow‐up study of patients in OAT (N = 2694 at baseline).
Michael Soyka, Gabi Koller, Wittchen Hans‐Ulrich, Gerhard Bühringer   +3 more
wiley   +1 more source

Ethnic diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of heroin addicts

, 2010
David A. Nielsen, Sara Hamon, Vadim Yuferov, Colin Jackson, Ann Ho, Jürg Ott, Mary Jeanne Kreek   +6 more
openalex   +2 more sources

<i>Kappa</i>-opioid receptor gene (<i>OPRK1</i>) variations associated with opioid abstinence behaviors among chronic heroin users. [PDF]

Front Pharmacol
Greenwald MK, Demery C, Moses TEH, Burmeister M.   +3 more
europepmc   +1 more source